| Literature DB >> 27255519 |
Walaa G Hozayen1,2, Mohamed A El-Desouky3, Hanan A Soliman4, Rasha R Ahmed5, Amal K Khaliefa4.
Abstract
BACKGROUND: Glucocorticoid-induced osteoporosis (GIO) is one of the serious side effects which have become the most common secondary osteoporosis. The purpose of this study is to evaluate the effect of aqueous extract of parsley, basil and chicory on glucocorticoid-induced osteoporosis in rats.Entities:
Keywords: Bone biomarkers; Dexamethasone; Histopathology and oxidative stress; Osteoporosis
Mesh:
Substances:
Year: 2016 PMID: 27255519 PMCID: PMC4891838 DOI: 10.1186/s12906-016-1140-y
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Fig. 1HPLC chromatogram (250-350 nm) of the flavonoid compounds of: a: Petroselinum crispum leaf. The peaks were identified (1) luteo.6-arabinose8-glucose, (2) luteo.6-glucose8-arabinose, (3) apig.6-rhaminose8-glucose, (4) apig.6-glucose8-rhaminose, (5) naringin, (6) rutin, (7) hespirdin, (8) rosmarinic, (9) apig.7-o-neohespiroside, (10) apiginin-7-glucose, (11) quercetrin, (12) quercitin, (13) naringenin, (14) hespirtin, (15) kampferol, (16) apigenin. b: Ocimum basilicum leaf. The peaks were identified (1) luteo.6-arabinose8-glucose, (2) luteo.6-glucose8-arabinose, (3) apig.6-rhaminose8-galactose, (4) apig.6-rhaminose8-glucose, (5) apig.6-glucose8-rhaminose, (6) rutin, (7) hespirdin, (8) rosmarinic, (9) apig.7-o-neohespiroside, (10) apiginin-7-glucose, (11) quercitin, (12) naringenin, (13) hespirtin, (14) kampferol, (15) apigenin. c: Cichorium intybus L. leaf. The peaks were identified (1) luteo.6-arabinose8-glucose, (2) luteo.6-glucose8-arabinose, (3) apig.6-rhaminose8-galactose, (4) naringin, (5) hespirdin, (6) rosmarinic acid
Fig. 2HPLC chromatogram of the saccharide compounds of: a: Petroselinum crispum leaf. The peaks were identified (1) sucrose, (2) glucose, (3) rhaminose, (4) mannose, (5) arabinose, (6) manitol. b: Ocimum basilicum leaf. The peaks were identified (1) glucuronic acid, (2) stachyose, (3) sucrose, (4) glucose, (5) xylose, (6) rhaminose, (7) arabinose, (8) manitol. c: Cichorium intybus L. leaf. The peaks were identified (1) inulin, (2) stachyose, (3) sucrose, (4) glucose, (5) mannose, (6) fructose
Serum mineral parameters, enzyme activities in control and different treated groups
| Groups | Normal | Dex. | Dex. + parsley | Dex. + basil | Dex. + chicory | PANOVA | LSD at 5 % | LSD at 1 % |
|---|---|---|---|---|---|---|---|---|
| Parameters | ||||||||
| E2 (Pg/ml) | 32.3 ± 6.45a | 17.4 ± 0.86c | 26.4 ± 2.31b | 26.4 ± 0.38b | 23.1 ± 0.73b |
| 3.699 | 5.006 |
| PTH (Pg/ml) | 8.36 ± 1.19d | 17.4 ± 2.56a | 14.0 ± 1.71b | 15.6 ± 0.87ab | 11.7 ± 0.91c |
| 1.882 | 2.546 |
| Ca (mg/dl) | 9.94 ± 1.14a | 5.49 ± 0.38c | 7.05 ± 0.63b | 6.69 ± 0.83b | 6.66 ± 0.62b |
| 0.908 | 1.228 |
| P (mg/dl) | 8.82 ± 0.39a | 5.63 ± 0.46c | 7.42 ± 1.07b | 6.88 ± 0.69b | 7.46 ± 0.81b |
| 0.851 | 1.152 |
| ALP (IU/L) | 199 ± 30.9b | 393 ± 17.7a | 202 ± 14.3b | 203 ± 14.6b | 210 ± 31.0b |
| 27.38 | 37.05 |
| ACP (IU/L) | 11.6 ± 2.16d | 23.7 ± 1.62a | 17.6 ± 2.93b | 13.9 ± 1.62cd | 16.5 ± 2.89bc |
| 2.758 | 3.731 |
Data are expressed as mean ± S.D. N = 6 animals per group
Mean with the different letters in the row are significantly different
Dex. dexamethasone, E2 estradiol, PTH parathyroid hormone, Ca calcium, P phosphorus, ALP alkaline phosphatase, ACP acid phosphatase
Bone mineral parameters and bone enzyme activities in control and different treated groups
| Groups | Normal | Dex. | Dex. + parsley | Dex. + basil | Dex. + chicory | PANOVA | LSD at 5 % | LSD at 1 % |
|---|---|---|---|---|---|---|---|---|
| Parameters | ||||||||
| Ca (mg/g T) | 15.9 ± 1.15a | 10.2 ± 1.03d | 15.5 ± 0.55ab | 14.4 ± 0.93b | 12.8 ± 0.75c |
| 1.081 | 1.463 |
| P (mg/g T) | 15.7 ± 0.49a | 7.02 ± 0.16d | 7.22 ± 0.47d | 9.77 ± 0.91c | 14.2 ± 0.72b |
| 0.716 | 0.969 |
| ALP (IU/g T) | 1186 ± 193d | 2008 ± 89.2a | 1396 ± 119b | 1323 ± 94.9cd | 1365 ± 142b |
| 157.9 | 213.6 |
| ACP (IU/g T) | 194 .1 ± 1.6b | 213.1 ± 6.14a | 197.6 ± 4.84b | 195.9 ± 3.29b | 195.1 ± 6.04b |
| 5.612 | 7.593 |
Data are expressed as mean ± S.D. N = 6 animals per group
Mean with the different letters in the row are significantly different
Dex. dexamethasone, Ca calcium, P phosphorus, ALP alkaline phosphatase, ACP acid phosphatase
Bone mineral density and bone mineral contents in different areas in femur bone of control and different treated groups
| Groups | Normal | Dex. | Dex. + parsley | Dex. + basil | Dex. + chicory | PANOVA | LSD at 5 % | LSD at 1 % |
|---|---|---|---|---|---|---|---|---|
| Parameters | ||||||||
| Total BMD (mg/cm2) | 60.5 ± 7.85a | 38.7 ± 2.64c | 50.9 ± 7.26b | 51.5 ± 1.70b | 55.5 ± 3.24bc |
| 6.176 | 8.355 |
| Prox. BMD (mg/cm2) | 55.8 ± 8.91a | 43.9 ± 3.77c | 52.2 ± 3.22ab | 49.5 ± 2.12bc | 52.7 ± 3.55ab |
| 5.853 | 7.919 |
| Mid. BMD (mg/cm2) | 69.0 ± 8.63a | 38.2 ± 3.64d | 61.7 ± 2.34b | 54.7 ± 5.02c | 54.9 ± 3.05c |
| 6.014 | 8.136 |
| Dist. BMD (mg/cm2) | 52.6 ± 6.63a | 47.5 ± 6.61a | 51.7 ± 4.79a | 49.3 ± 3.86a | 50.4 ± 4.13a |
| - | - |
| Total BMC (mg) | 83.0 ± 7.25a | 28.5 ± 5.15d | 50.4 ± 5.76c | 60.8 ± 8.29b | 55.0 ± 1.73bc |
| 7.271 | 9.837 |
| Prox. BMC (mg) | 43.6 ± 7.32a | 12.4 ± 1.52c | 27.3 ± 3.47b | 24.5 ± 3.01b | 25.0 ± 4.63d |
| 5.277 | 7.139 |
| Mid. BMC (mg) | 25.6 ± 4.17a | 8.05 ± 1.33d | 12.3 ± 1.56c | 18.4 ± 3.19b | 10.6 ± 0.78cd |
| 3.027 | 4.096 |
| Dist. BMC (mg) | 26.1 ± 2.87a | 13.6 ± 2.49c | 21.2 ± 1.03b | 24.0 ± 2.47a | 24.3 ± 0.87a |
| 2.541 | 3.401 |
Data are expressed as mean ± S.D. N = 6 animals per group
Mean with the different letters in the row are significantly different
Dex. dexamethasone, BMD bone mineral density, BMC bone mineral content, Prox. proximal, Mid. middle, Dist. distal
Bone oxidative stress marker and antioxidant parameters in control and different treated groups
| Groups | Normal | Dex. | Dex. + parsley | Dex. + basil | Dex. + chicory | PANOVA | LSD at 5 % | LSD at 1 % |
|---|---|---|---|---|---|---|---|---|
| Parameters | ||||||||
| TBARS (nmol/g T) | 18.1 ± 2.38c | 56.3 ± 8.03a | 32.1 ± 3.96b | 30.4 ± 4.97b | 23.5 ± 3.61c |
| 5.912 | 7.998 |
| GSH (mg/g T) | 6.76 ± 1.21a | 2.37 ± 0.33c | 2.96 ± 0.53bc | 2.61 ± 0.54bc | 3.49 ± 0.96b |
| 0.931 | 1.260 |
| GST (U/g T) | 2155 ± 254a | 1277 ± 44.7d | 1533 ± 59.2c | 1648 ± 77.2bc | 1741 ± 131b |
| 162.2 | 219.4 |
| GPx (U/g T) | 109 ± 21.7a | 69.9 ± 7.58b | 102 ± 11.5a | 103 ± 16.5a | 99.0 ± 13.8a |
| 18.08 | 24.46 |
| GR (U/g T) | 457 ± 67.9a | 272 ± 70.7b | 341 ± 88.6b | 320 ± 55.9b | 340 ± 91.2b |
| 90.40 | 122.3 |
| Cat (U/g T) | 0.97 ± 0.11a | 0.32 ± 0.06c | 0.37 ± 0.05c | 0.59 ± 0.09b | 0.88 ± 0.08a |
| 0.099 | 0.134 |
Data are expressed as mean ± S.D. N = 6 animals per group
Mean with the different letters in the row are significantly different
Dex. dexamethasone, TBARS thiobarbituric acid reactive substance, GSH glutathione reduced, GST glutathione s transferase, GPx glutathione peroxidase, GR glutathione reductase, Cat catalase.
Fig. 3Photomicrographs of rat femur sections of different experimental groups stained with haematoxylin and eosin. (1 and 2): negative control group revealed no histopathological alteration in the condyle cartilaginous surface as well as the bony trabeculae and bone marrow. (3 and 4): the osteoporotic group revealed mild bone resorption in the trabeculae with intact Havarsian system. (5 and 6): Osteoporotic-treated rats with parsley extract showed bone resorption in the trabeculae associated with hypertrophy in the cartilaginous structure of the condyle and intact Haversian system in the shaft of the long bone. (7 and 8): rats treated with aqueous basil extract showed mild atrophy in the cartilaginous structure of the condyle with osteogenesis in the shaft. (9 and 10): rats treated with aqueous chicory extract revealed osteogenesis in both condyle and shaft of the long bone. X 100